Crossref journal-article
Elsevier BV
Journal of Controlled Release (78)
Authors 6
  1. J.E Eyles (first)
  2. E.D Williamson (additional)
  3. I.D Spiers (additional)
  4. A.J Stagg (additional)
  5. S.M Jones (additional)
  6. H.O Alpar (additional)
References 23 Referenced 36
  1. 10.4269/ajtmh.1998.58.793 / Am. J. Trop. Med. Hyg. / Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice by Anderson (1998)
  2. 10.1128/IAI.64.6.2180-2187.1996 / Infect. Immun. / Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge by Andrews (1996)
  3. 10.1128/IAI.63.8.2854-2858.1995 / Infect. Immun. / Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague by Leary (1995)
  4. 10.1093/oxfordjournals.bmb.a011715 / Br. Med. Bull. / Plague by Titball (1998)
  5. 10.1111/j.1574-695X.1995.tb00196.x / FEMS Immun. Med. Microbiol. / A new improved subunit vaccine for plague: the basis of protection by Williamson (1995)
  6. 10.1016/S0264-410X(97)00249-1 / Vaccine / Intranasal administration of poly lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse by Eyles (1998)
  7. 10.1128/IAI.65.5.1926-1930.1997 / Infect. Immun. / Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague by Titball (1997)
  8. 10.1016/S0264-410X(98)00089-9 / Vaccine / Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis subunit vaccines by Eyles (1998)
  9. 10.1016/S0264-410X(96)00303-9 / Vaccine / A subunit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague by Williamson (1997)
  10. 10.1016/S0264-410X(96)00151-X / Vaccine / Local and systemic immune response to a microencapsulated subunit vaccine for plague by Williamson (1996)
  11. 10.1016/0142-9612(93)90121-H / Biomaterials / Poly(l-lactide): a long-term degradation study in vivo by Pistner (1993)
  12. 10.3109/02652049809008253 / J. Microencapsulation / Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability by Crotts (1998)
  13. 10.1016/S0264-410X(96)00098-9 / Vaccine / Adjuvant effect of biodegradable poly(dl-lactic acid) granules capable for antigen release following intraperitoneal injection by Nakaoka (1996)
  14. 10.1016/0169-409X(93)90014-U / Adv. Drug Deliv. Rev. / Mucociliary clearance and drug delivery via the respiratory tract by Batts Lansley (1993)
  15. 10.1111/j.2042-7158.1993.tb05532.x / J. Pharm. Pharmacol. / Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(l-lactic acid) microspheres in rats, rabbits and guinea pigs by Almeida (1993)
  16. 10.3109/10611869609015965 / J. Drug Targeting / Nasal delivery of vaccines by Almeida (1996)
  17. 10.1046/j.1365-2567.1998.00420.x / Immunology / Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes by Heritage (1998)
  18. 10.1007/BF02786362 / Immunol. Res. / Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system by Wu (1997)
  19. 10.1016/S0378-5173(99)00239-2 / Int. J. Pharm. / Immunological responses to nasal delivery of free and microencapsulated tetanus toxoid: studies on the effect of vehicle volume by Eyles (1999)
  20. 10.1128/iai.29.2.654-662.1980 / Infect. Immun. / Outcome of influenza infection: effect of site of initial infection and heterotypic immunity by Yetter (1980)
  21. {'key': '10.1016/S0168-3659(99)00197-2_BIB21', 'first-page': '1005', 'article-title': 'Inductive pathways leading to rat tear IgA antibody responses', 'volume': '39', 'author': 'Ridley Lathers', 'year': '1998', 'journal-title': 'Invest. Opthalmol. Vis. Sci.'} / Invest. Opthalmol. Vis. Sci. / Inductive pathways leading to rat tear IgA antibody responses by Ridley Lathers (1998)
  22. 10.3109/10611869409015903 / J. Drug Targeting / Microspheres absorption by the nasal mucosa of the rat by Alpar (1994)
  23. {'key': '10.1016/S0168-3659(99)00197-2_BIB23', 'series-title': 'Vaccine Design: The Subunit and Adjuvant Approach', 'first-page': '1', 'article-title': 'Immunological and formulation design considerations for subunit vaccines', 'author': 'Newman', 'year': '1995'} / Vaccine Design: The Subunit and Adjuvant Approach / Immunological and formulation design considerations for subunit vaccines by Newman (1995)
Dates
Type When
Created 23 years, 1 month ago (July 25, 2002, 2:51 p.m.)
Deposited 2 years, 4 months ago (April 11, 2023, 8:33 p.m.)
Indexed 3 weeks, 4 days ago (Aug. 2, 2025, 1:19 a.m.)
Issued 25 years, 7 months ago (Jan. 1, 2000)
Published 25 years, 7 months ago (Jan. 1, 2000)
Published Print 25 years, 7 months ago (Jan. 1, 2000)
Funders 0

None

@article{Eyles_2000, title={Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits}, volume={63}, ISSN={0168-3659}, url={http://dx.doi.org/10.1016/s0168-3659(99)00197-2}, DOI={10.1016/s0168-3659(99)00197-2}, number={1–2}, journal={Journal of Controlled Release}, publisher={Elsevier BV}, author={Eyles, J.E and Williamson, E.D and Spiers, I.D and Stagg, A.J and Jones, S.M and Alpar, H.O}, year={2000}, month=jan, pages={191–200} }